Nova Patents
ATE217525T1

Spheroids containing tiagabine, preparation process and pharmaceutical compositions

Abstract

The present invention relates to a novel pharmaceutical form, in the form of spheroids, containing tiagabine as active principle. The invention also covers the process for the preparation of such spheroids and multiparticulate pharmaceutical preparations, such as tablets, containing these spheroids. These pharmaceutical preparations are intended for the delivery of the spheroids they contain, and are characterized by the absence of an adverse effect on the release profile of the tiagabine contained in the spheroids following a possible compression step.

Term

Term ended

Projected expiry passed 19 November 2018, 7.8 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

68 members in 31 offices

This recordMember, by publication datePriority claim21 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
9714635FranceA
9801910International Bureau of the World Intellectual Property Organization (WIPO)W

Members68

Family members, oldest first
DocumentOfficeKind
ZA9810630BSouth AfricaB
ZA9810631BSouth AfricaB
FR2771291A1FranceA1
FR2771292A1FranceA1
CA2310147A1CanadaA1
WO9926608A1World Intellectual Property Organization (WIPO)A1
WO9926626A1World Intellectual Property Organization (WIPO)A1
AU1170399AAustraliaA
AU1170499AAustraliaA
FR2771292B1FranceB1
FR2771291B1FranceB1
NO20002605D0NorwayD0
US6077544AUnited States of AmericaA
NO20002605LNorwayL
EP1032374A1European Patent Office (EPO)A1
EP1032391A1European Patent Office (EPO)A1
BR9814672ABrazilA
CZ20001849A3CzechiaA3
US6139877AUnited States of AmericaA
TR200002130T2TürkiyeT2
EA200000548A1Eurasian Patent Organization (EAPO)A1
CN1282239AChinaA
PL340659A1PolandA1
KR20010032329ARepublic of KoreaA
BG104511ABulgariaA
IL136215D0IsraelD0
SK7562000A3SlovakiaA3
HRP20000323A2CroatiaA2
AR017652A1ArgentinaA1
JP2001523706AJapanA
JP2001523719AJapanA
AU744580B2AustraliaB2
EP1032391B1European Patent Office (EPO)B1
HU0100562A2HungaryA2
HUP0100562A2HungaryA2
AT217525TAustriaT
ATE217525T1This recordAustriaT1
DE69805433D1GermanyD1
HU0100562A3HungaryA3
HUP0100562A3HungaryA3
DK1032391T3DenmarkT3
NZ504662ANew ZealandA
PT1032391EPortugalE
ES2173638T3SpainT3
MXPA00004959AMexicoA
DE69805433T2GermanyT2
YU31000AYugoslavia, later Serbia and Montenegro (until 2006)A
EA003324B1Eurasian Patent Organization (EAPO)B1
EP1032374B1European Patent Office (EPO)B1
AT246496TAustriaT
ATE246496T1AustriaT1
DE69817010D1GermanyD1
SI1032374T1SloveniaT1
DK1032374T3DenmarkT3
PT1032374EPortugalE
ES2203989T3SpainT3
DE69817010T2GermanyT2
SK284493B6SlovakiaB6
KR100502938B1Republic of KoreaB1
CN1223341CChinaC
HRP20000323B1CroatiaB1
IL136215AIsraelA
BG65117B1BulgariaB1
PL193878B1PolandB1
CZ299110B6CzechiaB6
CA2310147CCanadaC
NO329728B1NorwayB1
HU230053B1HungaryB1